Compare compound mechanisms, evidence quality, related research topics, receptor considerations, and live COA-verified prices. Add 1–5 compounds.
Research signals
Redundancy, true conflicts, and dangerous additive effects
Review advised
No documented conflicts — some notes to review
Receptor activity map
| Receptor | GHK-Cu | KPV | Triple Agon… |
|---|---|---|---|
| NFκB / p65RelA nuclear signaling | |||
| Collagen / ECM / matrix remodeling | |||
| Copper-dependent enzyme systems | |||
| MC3R (melanocortin 3 receptor) | |||
| GLP-1R (glucagon-like peptide-1 receptor) | |||
| GIPR (glucose-dependent insulinotropic polypeptide receptor) | |||
| GCGR (glucagon receptor) |
A structured review of the evidence for this stack
Sign in to build a structured evidence review for Triple Agonist + GHK-Cu + KPV — mechanisms, evidence, endpoints, and limitations grounded in documented research.
Aggregate research activity for this selection
No researchers have logged this exact combination yet — yours could be the first.
Forum discussions on this stack
0 replies
Researchers are also adding
Best price for each compound today
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.